Status: Recruiting
Autoimmune Blistering Diseases Study
Pemphigus and bullous pemphigoid (BP) are severe autoimmune blistering diseases (AIBD) that pose a critical need for new therapeutic approaches. Clinical trials in pemphigus and BP will require the availability of validated disease severity measures that can be used to define primary outcomes.
Participants needed: 150
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University of PennsylvaniaUpdated: Mar 30, 2026Locations: 3Duration: 3 Years
Eligibility criteria
Gender/Age: Males or females above 18 years old [+2]
Patients who are under age 18 years. [+4]